Long-Acting HIV Treatment Maintains Viral Suppression in 94% of Patients

Long-Acting HIV Treatment Maintains Viral Suppression in 94% of Patients

Audio narration · Coming soon

This announcement highlights the effectiveness of a long-acting HIV treatment that maintained viral suppression in 94% of patients. The treatment showed a low virologic failure rate of just 1%, indicating promising results for managing HIV.

Why this matters

PRISM scored this story 65/100 for interest.

Originally published by gnews